Dik J. Kwekkeboom
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 18, 2019
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 17, 2017
Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 19, 2017
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Journal: Endocrine-related cancer
Published: March 16, 2017
Somatostatin Receptor 2-Targeting Compounds.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2017
Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
Journal: BMC gastroenterology
Published: January 23, 2017
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Journal: The New England journal of medicine
Published: January 12, 2017
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.
Journal: Neuroendocrinology
Published: December 12, 2016
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
Journal: Neuroendocrinology
Published: December 05, 2016
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 31, 2016
Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
Journal: Clinical nuclear medicine
Published: October 25, 2016
Last Updated: 09/26/2026